Epilepsy and pregnancy;Epilepsia y embarazo

Revista de Neurologia

Volumn 33, Issue 12, 2001, Pages 1179-1185

  Domínguez, Manuel ^a   Diaz Obregon M C ^a   Bhathal, H ^a   Santiago, R ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Antiepileptic drugs; Congenital malformations; Epilepsy; Foetus; Lamotrigine; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; DOSE CALCULATION; EPILEPSY; FEMALE; FETOTOXICITY; FETUS; FETUS MALFORMATION; FETUS MONITORING; HUMAN; INCIDENCE; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; REVIEW; SEIZURE SUSCEPTIBILITY; SYNDROME DELINEATION;

EID: 0035711113     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3312.2001235     Document Type: Review

References (73)

1. Analysis of prenatal and gestational care given to women with epilepsy
2. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy
3. Pregnancy and epilepsy
4. Epilepsy and pregnancy: A study of 153 pregnancies in 59 patients
5. Higher risk of seizures in offspring of mothers than of fathers with epilepsy
6. Epilepsy in pregnancy: Developmental outcome of offspring at 12 months
7. Maternal seizure disorder, outcome of pregnancy and neurologic abnormalities in the children
8. Epilepsy and pregnancy
9. Change of seizure frequency in pregnant epileptic women
10. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: A multiple-center prospective study
11. Epilepsy an pregnancy
12. A maternal complex partial seizure in labor can affect fetal heart rate
13. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations
14. Seizures, anticonvulsants, and pregnancy
15. Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring
16. Instructions for use of the reference guide
17. Status epilepticus in pregnancy: Effect of phenytoin malabsorption on seizure control
18. Plasma protein binding of drugs in pregnancy
19. Anticonvulsants during pregnancy and lactation: Transplacental, maternal and neonatal pharmacokinetics
20. Antiepileptic drugs and pregnancy: Altered utilization patterns and teratogenesis
21. Relation of epileptic symptoms to pregnancy, delivery and puerperium
22. Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding
23. Epilepsy and pregnancy: Mother and child
24. Fetal death, malformations and infant mortality in infants of mothers with epilepsy
25. Epilepsy, pregnancy, and major birth anomalies: An Italian prospective, controlled study
26. Reproduction among individuals with idiopathic/cryptogenic epilepsy: Risk factors for spontaneous abortion
27. Outcome of pregnancy and postnatal follow-up in offspring of epileptic mothers: A prospective study
28. Current concepts and controversies in the use of vitamin K
29. Effect of maternal anticonvulsant treatment on neonatal blood coagulation
30. Supplementation of vitamin K in pregnant women receiving anticonvulsant prevents neonatal vitamin K deficiency
31. ACOG Education bulletin. Seizures disorders in pregnancy
32. Consensus guidelines: Preconception counseling, management and care of the pregnant woman with epilepsy
33. Pregnancies of women with epilepsy: A population-based study in Iceland
34. Epilepsy and pregnancy: A report from the Oxford Record Linkage study
35. Major malformations and minor anomalies in infants exposed to different antiepileptic drugs during pregnancy
36. Teratogenicity of antiepileptic drugs
37. Malformations in offspring of women with epilepsy: A prospective study
38. Teratogenic effects of antiepileptic drugs: Use of an international database on malformations and drug exposure
39. Multi-institutional study of teratogenicity an fetal toxicity of anticonvulsant: A report of collaborative group in Japan
40. Congenital malformations and seizure disorders in the offspring of parents with epilepsy
41. The teratogenicity of anticonvulsant drugs
42. Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy
43. Drug and environmental factors associated with adverse pregnancy outcomes. Part I. Antiepileptic drugs, contraceptives, smoking and folate
44. Embryopathy during pregnancy caused by taking anticonvulsants
45. Anticonvulsants drugs and congenital abnormalities
46. Pharmacogenetic susceptibility to phenytoin teratogenesis
47. Antiepileptic drug regimens and major congenital abnormalities in the offspring
48. Maternal valproic acid and congenital neural tube defects
49. In-utero exposure to valproate and neural-tube defects
50. Spina bifida in infants of women treated with carbamazepine during pregnancy
51. Teratogenic effects of antiepileptic drugs: Implications for management of epilepsy in women of childbearing age
52. Digit effects produced by prenatal exposure to antiepileptic drugs
53. Epilepsy and pregnancy: Effect of antiepileptic drugs and lifestyle on birth weight
54. Pregnancy and teratogenesis
55. Congenital anomalies in children of epileptic mother and fathers
56. Epilepsy and pregnancy
57. Birth defects and supplemental vitamins
58. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
59. Folic acid antagonists pregnancy and the risk of birth defects
60. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
61. Best practice guidelines for the management of women with epilepsy
62. Guidelines for the care of women with epilepsy
63. Maximizing the health of women with epilepsy: Science and ethics in the new drug development
64. The new antiepileptic drugs and women: Efficacy, reproductive health, pregnancy and fetal outcome
65. Epilepsy, pregnancy and vigabatrin
66. Monitoring birth outcomes in the lamotrigine pregnancy registry
67. Interim results from the Lamotrigine Pregnancy Registry
68. International interim update: 1 september 1992 through 31 march 1999
69. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy
70. Lamotrigine in pregnancy
71. Safety of long-term lamotrigine in epilepsy
72. Epilepsy in women: The science of why is special
73. Beneficio terapéutico de la monoterapia con lamotrigina